computer software program for statistics for the apple macintosh jmp, version 3.0.5, statistics made visual (SAS institute)
90
Structured Review
SAS institute
computer software program for statistics for the apple macintosh jmp, version 3.0.5, statistics made visual
Computer Software Program For Statistics For The Apple Macintosh Jmp, Version 3.0.5, Statistics Made Visual, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+statistical+analysis+software+program/computer+software+program+for+statistics+for+the+apple+macintosh+jmp++version+3+0+5++statistics+made+visual/pm09631862-60-21-22
Average 90 stars, based on 1 article reviews
Computer Software Program For Statistics For The Apple Macintosh Jmp, Version 3.0.5, Statistics Made Visual, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+statistical+analysis+software+program/computer+software+program+for+statistics+for+the+apple+macintosh+jmp++version+3+0+5++statistics+made+visual/pm09631862-60-21-22
Average 90 stars, based on 1 article reviews
computer software program for statistics for the apple macintosh jmp, version 3.0.5, statistics made visual - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Efficacy Endpoints Conference on Acute Rejection in Kidney Transplantation: summary report of the database. Article Snippet: ● An international database of rejection episodes and their characteristics with regard to definition and follow-up parameters was developed to improve the approach to protocol development for clinical trials.. Nineteen North American, European, and Australian centers uniformly reported on 50 consecutive transplant rejection episodes.. Data collected included patient demographic parameters, induction and maintenance immunosuppression therapies, rejection agents (drug, dose, duration), clinical signs (50% decrease in urine, fever), serum creatinine (nadir, at rejection, daily during antirejection therapy to 15 days, and days 30, 90, 180, and 365 after rejection date), histopathological findings, morbidity, recurrence of rejection, and function at 1 year. |